Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by CdnWeston Jan 28, 2016 6:41pm

97 Views

Post# 24503726

RE:Zika Virus seems to be a major concern

Microbix produces antigens used in testing for virus presence. You can see they are world experts in Dengue fever. The Zika virus shares the same mosquito host as Dengue too. Anyway, CDC says: "There are no commercially-available diagnostic assays or kits for Zika virus infection.". (reference)

It would be a great service to humanity, if Microbix could get there new bioreator churning out antigens in support of a decent testing kit. Even if there wasn't a lot of money to be made. Because it is not all about the money.

CdnWest

Bullboard Posts

This battery metals stock is on a path to the global stage